Mark Shusterman

Mark Shusterman has been the Medical Director of Oraya Therapeutics for over six years. In addition to his duties with Oraya, Mark has a long-standing interest in aerospace medicine, and has served as a Flight Surgeon with the United States Air Force for the past 17 years.

Content by Mark Shusterman:

Subspecialties Retina

An Intrepid Assault on AMD

08/31/2013 | Mark Shusterman

Stereotactic radiation therapy is a new treatment aimed at wet age-related macular degeneration. The results of a randomized, sham-controlled trial are encouraging.